ImmuPharma plc (LON:IMM – Get Free Report)’s share price traded up 23.5% during trading on Friday . The stock traded as high as GBX 4.70 ($0.06) and last traded at GBX 4.32 ($0.05). 86,096,039 shares changed hands during mid-day trading, an increase of 204% from the average session volume of 28,338,043 shares. The stock had previously closed at GBX 3.50 ($0.04).
ImmuPharma Trading Up 23.5 %
The stock’s 50 day moving average is GBX 1.40 and its 200 day moving average is GBX 1.65. The stock has a market capitalization of £18.00 million, a price-to-earnings ratio of -432.20 and a beta of 1.53.
ImmuPharma Company Profile
ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease.
Read More
- Five stocks we like better than ImmuPharma
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- 3 EV Stocks Offering Unique Alternatives to Tesla
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- 3 Stocks Leveraging NVIDIA’s Strength for Profits
- What is the S&P/TSX Index?
- Walgreens Stock Poised for a Rebound: Why Analysts Are Bullish
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
